Budget 2026: What Does It Mean for Founders, Investors and the UK Venture Ecosystem?

Viewpoints
November 2, 2026
6 minutes

The UK Chancellor has delivered Budget 2026. Below, we consider the key implications for UK venture capital investors and founders, and who is likely to benefit.

Key takeaways at a glance

  • A new Founders' Relief offering a 10% CGT rate on up to £10 million of lifetime gains.
  • Business Asset Disposal Relief lifetime limit to be halved to £500,000.
  • CSOP to be rebranded as EMI2, with the individual option limit doubled to £120,000.
  • R&D claims simplified, with the Claim Notification Form removed.
  • An additional £5 billion of British Business Bank capacity, including a new venture debt product.
  • Release of an updated VC-focused Prospectus document, Entrepreneurship in the UK: Start. Scale. Stay.
  • Only technical changes to SEIS, EIS and VCT.

Founders' Relief: a 10% rate for high-growth founders

From 6 April 2027, a new “Founders' Relief” will offer a 10% rate on up to £10 million of lifetime gains for qualifying founders of high-growth, innovative companies. The stated aim is to support founders building and scaling such companies in the UK. 

The proposed “qualifying founder” conditions (25% ownership of the ordinary shares pre-trading, and five-year share ownership and UK tax residence requirements) risk excluding some successful scale-ups while the prescriptive growth and innovation conditions (turnover, headcount and innovation, with two out of the three to be met) operate on a bright-line basis and will require particularly careful monitoring and structuring. The detailed conditions are the subject of a technical consultation, on a tight timescale, ahead of legislation in Finance Bill 2026-27.

Founders’ Relief has been welcomed by the industry as a responsive and targeted attempt to promote UK entrepreneurship but with certain reservations, in particular regarding the scope of the relief. The announced proposal has some rough edges which will need to be smoothed away to ensure it achieves the policy goals and the consultation phase will be particularly important. At the same time, the lifetime limit for Business Asset Disposal Relief (an 18% CGT rate) will fall from £1 million to £500,000 for disposals from 6 April 2027. Founders who fall outside the new relief may therefore be worse off while others expecting to rely on BADR (e.g., employees with large EMI gains) may be negatively impacted.

Equity incentives: from CSOP to EMI2

The Company Share Option Plan ("CSOP") is being rebranded as "EMI2". This casts it as a follow-on scheme to EMI although it continues to operate independently (or in parallel). The changes, effective from 6 April 2027, are substantive:

  • The individual option limit doubles from £60,000 to £120,000.
  • The exercise period is extended from 10 to 15 years.
  • The interaction between the CSOP and EMI limits will be removed, so eligible employees can hold up to £370,000 of options across the two schemes.

EMI itself also improves with effect from 6 April 2027, albeit more modestly than the significant extensions to scale-ups in Budget 2025. From 6 April 2027, the exercise window after a disqualifying event extends from 90 to 180 days. In an administrative but practically significant change announced at Budget 2025, grants of EMI options made from 6 April 2027 will no longer need to be separately notified to HMRC and will instead be reported in the annual Employment-Related Securities (EMI) return.

Put together, this package of liberalising measures has the potential to improve the reach and impact of the UK’s tax-advantaged employee incentivisation offer.

Venture capital schemes: technical tweaks, not a step change

SEIS, EIS and VCT will be made easier to use through a small number of technical changes which are generally effective from 6 April 2027. The Government will also strengthen guidance and compliance activity on excessive management and other fees (but will not impose a cap) and engage on improving the Advance Assurance service. With no wider enhancement of the schemes, some investors may read the Budget as favouring founders at exit over investors at entry.

R&D tax reliefs: less administration

Following a period of significant change to the UK’s R&D tax relief regime, the Government is also taking some welcome steps to address the administrative burden of that regime. From 1 April 2027, companies will no longer need to submit a Claim Notification Form, and the Additional Information Form will be simplified from autumn 2027. The Claim Notification Form and its associated hard filing deadline has proved to be a trap for the unwary and its removal is a welcome simplification.

Access to finance: more capital, with a focus on defence

The British Business Bank's financial capacity will increase by £5 billion. This includes £1.4 billion for equity funds backing high-growth businesses and £450 million for a new venture debt product. The venture debt product will be available to defence and dual-use technology companies, among others. The Bank also has a pipeline of over £100 million of commitments to women-led funds, and a new scale-up programme for women founders is planned.

The National Wealth Fund and British Business Bank will also deploy up to £5 billion of investment and lending over four years into defence, dual-use and other sectors supporting national security. Alongside this, the Government is establishing an Innovative Defence Financing Taskforce to maximise private and international finance for UK defence.

Separately, Scale UK, which supports high-growth businesses and scale-ups through targeted initiatives, will offer a "no wrong door" route to existing support. It will also create a pilot programme, Scale UK-Connect, to support 200 high-growth firms.

AI and life sciences: targeted investment

The Government will continue to invest in AI. An additional £140 million will go to the Sovereign AI Unit to help UK AI companies scale. This includes an extra £60 million for the Sovereign AI Fund's direct investments, with a new focus on physical AI, and £80 million for its R&D procurement scheme. The AI Security Institute receives an additional £120 million, and a new National AI Biosecurity Initiative receives £165 million.

For life sciences, the Government announced three public-private investments totalling over £1 billion, backed by almost £70 million in grants.

Talent and enterprise: removing barriers to hiring

The trading allowance triples from £1,000 to £3,000 from 6 April 2027. A Young Entrepreneurs Allowance pilot in England will give successful applicants support towards their living costs during the first year of their business.

Of particular interest to scale-ups, the Government will legislate so that non-compete clauses do not stop start-ups and scaling firms from hiring. A detailed position is due in early 2027.

On immigration:

  • The High Potential Individual visa will be expanded to eligible graduates of the top 150 global institutions, with a proportionate increase in the scheme's cap.
  • By spring 2027, UKRI will identify additional R&D-intensive businesses to act as host organisations on the Global Talent visa's endorsed-funder pathway.
  • From 2027, qualifying highly skilled workers will be able to access a visa curtailment period of up to six months, depending on how long they held their previous highly paid job.

Who are the winners?

The new Founders' Relief, rebranded and expanded EMI2 and a lighter R&D claims process are meaningful signals for the venture ecosystem, and founders and employees of high-growth companies are generally likely to welcome the Budget changes. The newly-published policy Prospectus, although relatively light on specific proposals, does indicate a positive direction of travel and a Government willing to engage with the industry. The decision not to raise CGT rates towards income tax rates, at least for now, may be the single most consequential decision emerging from the Budget and has avoided the real market disruption that this would have triggered.

It will not escape notice that the benefits of the changes are quite concentrated – for instance, despite lobbying efforts, early-stage capital has been overlooked and the VC schemes are not expanded – and as well as winners some will certainly lose out from the Budget. In particular, further restriction of BADR is not fully offset by the new Founders’ Relief, there are no measures to reverse increasing employment tax costs, while the confirmation of broad reforms of the UK tax treatment of returns of value from companies may adversely affect the tax treatment of well-established closely-held company transactions. 

Much will depend on the ongoing and forthcoming consultations, which we will be following closely, as well as future measures in this evolving area. Please get in touch with your Ropes & Gray contact if you would like to discuss how these changes may affect you or your portfolio.

Subscribe to Ropes & Gray Viewpoints by topic here.